Skip to search formSkip to main contentSkip to account menu

Coronary Restenosis

Known as: Coronary Restenoses, Coronary Restenosis [Disease/Finding], Restenoses, Coronary 
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
National Institutes of Health

Related topics

Related topics

6 relations
In BloodMicrobiologicalchemically inducednursing therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Clinical results with AGI-1067: a novel antioxidant vascular protectant.
Review
2002
Review
2002
Prevention of Restenosis with Antioxidants
The aim of this review is to give an overview of the field of restenosis prevention with antioxidants, put in the perspective of… 
1998
1998
Current status of radioactive stents for the prevention of in-stent restenosis.
1997
1997
Electron microscopic studies of phenotypic modulation of smooth muscle cells in coronary arteries of patients with unstable angina pectoris and postangioplasty restenosis.
BACKGROUND Proliferation and matrix protein secretion of coronary smooth muscle cells (SMCs) have been suggested as one of the… 
1995
1995
Interaction of human cytomegalovirus with p53: possible role in coronary restenosis.
Restenosis occurs in 25-50% of patients. Within 1-6 months after coronary angioplasty, excessive injury-induced smooth muscle… 
1995
1995
Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
BACKGROUND Clinical follow-up after percutaneous transluminal coronary angioplasty (PTCA) of an infarct-related lesion has… 
1994
1994
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?
1993
1993
Emergency coronary stenting with the Palmaz-Schatz stent for failed transluminal coronary angioplasty: results of a learning phase.
Highly Cited
1992
Highly Cited
1992
A Decrease in Plasminogen Activator Inhibitor-1 Activity after Successful Percutaneous Transluminal Coronary Angioplasty Is Associated with a Significantly Reduced Risk for Coronary Restenosis
Summary To determine a possible relation of changes in plasma levels of plasminogen activator inhibitor 1 (PAI-1) and tissue… 
1988
1988
Prevention of coronary restenosis by stenting.
Balloon angioplasty fails to provide acceptable long-term results for a significant proportion of patients. An intravascular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)